JTCS Sign the Guestbook
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fenton, K. N.
Right arrow Articles by Hanley, F. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fenton, K. N.
Right arrow Articles by Hanley, F. L.

The Journal of Thoracic and Cardiovascular Surgery, Vol 105, 502-510, Copyright © 1993 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association


ARTICLES

Exclusion of the placenta during fetal cardiac bypass augments systemic flow and provides important information about the mechanism of placental injury

KN Fenton, MK Heinemann and FL Hanley
Department of Cardiac Surgery, Children's Hospital, Harvard Medical School, Boston, Mass.

The in utero correction of congenital cardiac malformations requires the availability of fetal cardiac bypass. One difficulty with fetal cardiac bypass is that very high flow rates are necessary when the placenta is left in the bypass circuit; the placenta requires about 40% of fetal cardiac output, which results in a normal cardiac output of 400 ml/kg per minute. Previous attempts to perform fetal cardiac bypass failed to consistently achieve these high flow rates because of cannula size limitations. On the basis of previous work done in our laboratory with an isolated-placenta model, which demonstrated that at normothermia the placenta would tolerate at least 30 minutes of cessation of umbilical blood flow, we hypothesized that exclusion of the placenta from the fetal cardiac bypass circuit would reduce fetal cardiac output by one half and allow us to obtain better systemic perfusion without compromising placental function. Cardiac bypass was performed in 20 late-gestation fetal lambs. In 10 lambs, no drugs were given; 5 served as controls in which the placenta was perfused; in the last 5, the placenta was excluded by clamping the umbilical cord during bypass. The latter 10 lambs were treated with indomethacin, which is known to improve placental blood flow after fetal cardiac bypass. We measured blood gases and determined regional blood flow with radiolabeled microspheres to assess placental function after bypass. The 5 control fetuses experienced rapid hypercapnea and hypoxemia after bypass, in association with minimal placental blood flow; when the placenta was excluded, arterial carbon dioxide tension rose somewhat more slowly, and placental blood flow after bypass was significantly better. When indomethacin was given, arterial blood gases in both groups showed a mild increase in carbon dioxide tension and similar placental blood flows (about 30% of baseline) after bypass. Indomethacin is known to block the vasoconstrictive response of the placenta to fetal cardiac bypass, implicating the release of vasoactive cyclooxygenase products as the cause of the adverse effects. In this study, placental perfusion on bypass without indomethacin caused much more severe placental dysfunction than did bypass with the placenta excluded from the circuit. The use of indomethacin improved postbypass placental function in both groups, but this effect was much more dramatic in the placenta-perfused group.(ABSTRACT TRUNCATED AT 400 WORDS)


This article has been cited by other articles:


Home page
J. Thorac. Cardiovasc. Surg.Home page
R. S. Baker, C. T. Lam, E. A. Heeb, and P. Eghtesady
Dynamic fluid shifts induced by fetal bypass.
J. Thorac. Cardiovasc. Surg., March 1, 2009; 137(3): 714 - 722.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
C. T. Lam, S. Sharma, R. S. Baker, J. Hilshorst, J. Lombardi, K. E. Clark, and P. Eghtesady
Fetal Stress Response to Fetal Cardiac Surgery
Ann. Thorac. Surg., May 1, 2008; 85(5): 1719 - 1727.
[Abstract] [Full Text] [PDF]


Home page
PerfusionHome page
J. Lombardi, J. Sedgwick, J. Schenbeck, W. Lubbers, R. E Ferguson, A. Gardner, J. L McNamara, and P. Eghtesady
Cardiopulmonary bypass in the immature fetus through novel use of a mini-centrifugal pump
Perfusion, May 1, 2006; 21(3): 185 - 191.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
P. Eghtesady, J. A. Sedgwick, J. L. Schenbeck, C. Lam, J. Lombardi, R. Ferguson, A. Gardner, J. McNamara, and P. Manning
Maternal-Fetal Interactions in Fetal Cardiac Surgery
Ann. Thorac. Surg., January 1, 2006; 81(1): 249 - 256.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
Y. Oishi, M. Masuda, T. Yasutsune, N. Boku, S. Tokunaga, S. Morita, and H. Yasui
Impaired Endothelial Function of the Umbilical Artery After Fetal Cardiac Bypass
Ann. Thorac. Surg., December 1, 2004; 78(6): 1999 - 2003.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
S. P. Malhotra, S. Thelitz, R. K. Riemer, V. M. Reddy, S. Suleman, and F. L. Hanley
Fetal myocardial protection is markedly improved by reduced cardioplegic calcium content
Ann. Thorac. Surg., June 1, 2003; 75(6): 1937 - 1941.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
S. P. Malhotra, S. Thelitz, R. K. Riemer, V. M. Reddy, S. Suleman, and F. L. Hanley
Induced fibrillation is equally effective as crystalloid cardioplegia in the protection of fetal myocardial function
J. Thorac. Cardiovasc. Surg., June 1, 2003; 125(6): 1276 - 1282.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
R. S. Assad, F. Y. Lee, and F. L. Hanley
Placental compliance during fetal extracorporeal circulation
J Appl Physiol, May 1, 2001; 90(5): 1882 - 1886.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
R. S. Assad and F. L. Hanley
Editorial: Artificial placenta--a need for fetal surgery?
J. Thorac. Cardiovasc. Surg., May 1, 1998; 115(5): 1021 - 1025.
[Full Text] [PDF]


Home page
PerfusionHome page
J. J Sistino
Foetal bypass: concepts and controversies
Perfusion, March 1, 1998; 13(2): 111 - 117.
[Abstract] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
K. N. Fenton, M. K. Heinemann, P. R. Hickey, R. J. M. Klautz, J. R. Liddicoat, and F. L. Hanley
Inhibition of the fetal stress response improves cardiac output and gas exchange after fetal cardiac bypass
J. Thorac. Cardiovasc. Surg., June 1, 1994; 107(6): 1416 - 1422.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
K. N. Fenton, H. E. Zinn, M. K. Heinemann, J. R. Liddicoat, and F. L. Hanley
Long-term survivors of fetal cardiac bypass in lambs
J. Thorac. Cardiovasc. Surg., June 1, 1994; 107(6): 1423 - 1427.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1993 by The American Association for Thoracic Surgery.